These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10149510)

  • 21. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits.
    Svennevig JL; Geiran OR; Karlsen H; Pedersen T; Mollnes TE; Kongsgard U; Frøysaker T
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):466-72. PubMed ID: 8361189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo.
    Videm V; Mollnes TE; Bergh K; Fosse E; Mohr B; Hagve TA; Aasen AO; Svennevig JL
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):803-9. PubMed ID: 10096977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The evaluation of the bio-compatibility and the clinical usefulness of heparin-coated cardiopulmonary bypass circuits].
    Yamanaka J; Takeuchi Y; Torii S; Gomi A; Nakatani H; Kohno K
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Jan; 44(1):47-53. PubMed ID: 8683171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of heparin-bonded circuits in cardiopulmonary bypass improves clinical outcome.
    Svenmarker S; Häggmark S; Jansson E; Lindholm R; Appelblad M; Sandström E; Aberg T
    Scand Cardiovasc J; 2002 Aug; 36(4):241-6. PubMed ID: 12201973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
    Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
    ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation during cardiopulmonary bypass: effects of immobilized heparin.
    Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S
    Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model.
    Scholz T; Solberg R; Okkenhaug C; Videm V; Gallimore MJ; Mathisen O; Pedersen T; Mollnes TE; Bergan A; Søreide O; Klintmalm GB; Aasen AO
    Perfusion; 2001 Jul; 16(4):285-92. PubMed ID: 11486847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of heparin coated circuits on pulmonary injury. A clinical study.
    Kazaz H; Oto O; Sariosmanoglu N; Hazan E
    J Cardiovasc Surg (Torino); 2003 Oct; 44(5):611-5. PubMed ID: 14735048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-coated cardiopulmonary bypass circuits: current status.
    Hsu LC
    Perfusion; 2001 Sep; 16(5):417-28. PubMed ID: 11565897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass.
    Lundblad R; Moen O; Fosse E
    Ann Thorac Surg; 1997 May; 63(5):1361-7. PubMed ID: 9146328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients.
    Hamulu A; Dişcigil B; Ozbaran M; Calkavur T; Kara E; Kokuludağ A; Büket S; Bilkay O
    Perfusion; 1996 Jul; 11(4):333-7. PubMed ID: 8884862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving cardiopulmonary bypass: heparin-coated circuits.
    Vocelka C; Lindley G
    J Extra Corpor Technol; 2003 Dec; 35(4):312-6. PubMed ID: 14979422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.
    Fosse E; Moen O; Johnson E; Semb G; Brockmeier V; Mollnes TE; Fagerhol MK; Venge P
    Ann Thorac Surg; 1994 Aug; 58(2):472-7. PubMed ID: 8067851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
    Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
    Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Descending thoracic aortic aneurysm repair with the aid of partial cardiopulmonary bypass: heparin-coated circuits versus nonheparin-coated circuits.
    Morishita K; Kawaharada N; Fukada J; Hachiro Y; Kurimoto Y; Fujisawa Y; Saito T; Abe T
    Artif Organs; 2005 Apr; 29(4):300-5. PubMed ID: 15787624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.